Kidney Transplant

Nephrology

45 drugs in development·16 companies·6 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
Prevymis	Merck & Co., Inc. (MRK)
tacrolimus	Mylan II B.V. (MYL)

Phase 3(13)

Drug	Company
alemtuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
anti-cd20 antibodies	GT Biopharma, Inc. (GTBP)
anti-cd20 antibodies	POINT Biopharma Global Inc. (PNT)
belatacept	ENANTA PHARMACEUTICALS INC (ENTA)
belatacept	Cidara Therapeutics, Inc. (CDTX)
eculizumab	GT Biopharma, Inc. (GTBP)
eculizumab	POINT Biopharma Global Inc. (PNT)
frexalimab	Sanofi (SNY)
Frexalimab	Sanofi (SNY)
ivig	GT Biopharma, Inc. (GTBP)
ivig	POINT Biopharma Global Inc. (PNT)
ROVALCYTE	Crinetics Pharmaceuticals, Inc. (CRNX)
Tacrolimus	Sanofi (SNY)

Phase 2(12)

Phase 1(13)

Drug	Company
alemtuzumab	Cidara Therapeutics, Inc. (CDTX)
alemtuzumab	Accustem Sciences Inc. (ACUT)
belatacept	Accustem Sciences Inc. (ACUT)
carfilzomib	ENANTA PHARMACEUTICALS INC (ENTA)
carfilzomib	Cidara Therapeutics, Inc. (CDTX)
Donor-derived Mesenchymal Stromal Cells	Cidara Therapeutics, Inc. (CDTX)
Donor-derived Mesenchymal Stromal Cells	Accustem Sciences Inc. (ACUT)
mycophenolate acid	Accustem Sciences Inc. (ACUT)
mycophenolate mofetil	Cidara Therapeutics, Inc. (CDTX)
mycophenolate mofetil	Accustem Sciences Inc. (ACUT)
mycophenolate mofetil	ENANTA PHARMACEUTICALS INC (ENTA)
sirolimus	Accustem Sciences Inc. (ACUT)
sirolimus	Cidara Therapeutics, Inc. (CDTX)

Phase 1/Phase 2(1)

Drug	Company
at-1501	Eledon Pharmaceuticals, Inc. (ELDN)

Phase 2/Phase 3(4)

Drug	Company
mycophenolate	Sanofi (SNY)
mycophenolate mofetil	Sanofi (SNY)
rabbit anti-thymocyte globulin	Sanofi (SNY)
rabbit anti-thymocyte globulin	Sanofi (SNYNF)

BioSniper tracks 45 drugs in development for Kidney Transplant across 16 companies.

There are 6 clinical trials targeting Kidney Transplant tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.